A prenatal missed diagnosed case of submicroscopic chromosomal abnormalities by karyotyping: the clinical utility of array-based CGH in prenatal diagnostics by Aihua Yin et al.
Yin et al. Molecular Cytogenetics 2014, 7:26
http://www.molecularcytogenetics.org/content/7/1/26CASE REPORT Open AccessA prenatal missed diagnosed case of
submicroscopic chromosomal abnormalities by
karyotyping: the clinical utility of array-based CGH
in prenatal diagnostics
Aihua Yin1,2, Jian Lu1,2, Chang Liu2, Li Guo1,2, Jing Wu1,2, Mingqin Mai1,2, Yanfang Zhong1,2
and Xiaozhuang Zhang1,2*Abstract
Background: Array-based comparative genomic hybridization possesses a number of significant advantages over
conventional cytogenetic and other molecular cytogenetic techniques, providing a sensitive and comprehensive
detection platform for unexpected imbalances in the genome wide.
Case presentation: The newborn proband, demonstrated with craniofacial dysmorphism and multiple
malformations, was born to a family with spontaneous abortions. This pregnancy was uneventful, except the
prenatal ultrasound examination showed an increased nuchal translucency at 12+ weeks of gestation. Cytogenetics
revealed an apparently normal karyotype, and the couple decided to continue the pregnancy. Array-based CGH
analysis was applied to the affected infant, identified a combination of 18p deletion and 7q duplication. Further
study indicates that the unbalanced translocation was inherited from a balanced translocation carrier parent.
Conclusions: In review of the case, several overlooked points leading to the missed diagnosis should be discussed
and certain quality control strategies should be adopted to avoid similar problems in the future. Array-based CGH and
karyotyping techniques are complemented by diverse detection spectrum and resolutions, and a combination of
these methods could help providing optimal genetic diagnosis. Given that the array-CGH analysis will not introduce
additional risk to patients, it is reasonable to recommend those already undergoing invasive testing should take
array-based CGH as an adjunct to conventional cytogenetic tests and other molecular cytogenetic analysis.
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Karyotyping is the predominant technique for prenatal
diagnosis of chromosomal abnormalities, but most chro-
mosome banding techniques are time-consuming and
limited to resolutions of 5 to 10 Mb [1,2]. As prior stu-
dies indicated, conventional karyotyping only identify
chromosomal anomalies in about 35% of pregnancies
with fetal ultrasound abnormalities, depending on the
types of these anomalies [3]. Molecular cytogenetic tech-
niques such as fluorescent in situ hybridisation (FISH),* Correspondence: zhangxiaozhuang55@126.com
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unless otherwise stated.quantitative fluorescent PCR (QF-PCR) and multiplex
ligation-dependent probe amplification (MLPA) overcome
some of those limitations and are used as adjuncts to con-
ventional methods for detecting common chromosome
numerical anomalies [1], but none of them provides a
genome wide screening for unexpected imbalances [4].
Fortunately, array-based comparative genomic hybri-
dization (array-based CGH) technology can simulta-
neously evaluate regions across the entire genome and
allowed for detection of unbalanced structural and nu-
merical chromosome abnormalities of less than 100 kb
[5]. The array-based CGH platform used for clinical
prenatal diagnosis is able to enhance the detection rate
by 10 to 16 percent of pregnancies with fetal ultrasound. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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or other molecular cytogenetic techniques [6-9].
In this report, we present a prenatal missed diagnosed
case of submicroscopic chromosomal abnormalities by
karyotyping, and try to demonstrate the clinical utility of
array-based CGH in prenatal diagnostics by providing a
retrospective analysis of those overlooked points leading
to the missed diagnosis of the case.
Case presentation
Clinical description
The proband, a 1-day-old boy, was the first child of non-
consanguineous, healthy 35 year-old parents. The couple
had a past history of twice spontaneous abortions both oc-
curred between 7 and 10 weeks of gestation, but product-
of-conception (POC) samples were not analyzed. The
cytogenetic analyses of the couple preformed at another
hospital revealed apparent normal karyotypes. This preg-
nancy was uneventful, and there was no prenatal exposure
to teratogens. However, the prenatal ultrasound exami-
nation showed an increased nuchal translucency (4.0 mm)
at 12+ weeks of gestation. Taking into account of the ad-
vanced maternal age as well, interventional prenatal diag-
nosis was referred to the couple. After understanding
detailed information about sampling procedures, the riskFigure 1 GTG banded karyotype of the fetus. The karyotype revealed aof fetal mortality and the limitations of the testing,
the couple decided to receive an amniocentesis at 18
weeks of gestation for further diagnosis. Amniotic
fluid cells were cultured in situ and their karyotypes
were analyzed by using G-banding technique [10], the
cytogenetics revealed a apparently normal karyotype
46,XY (Figure 1).
Following ultrasound examinations showed an increased
size in dimensions of biparietal diameter and abdominal
circumference, fetal cerebral ventriculomegaly, increased
nuchal folder, polyhydramnios. However, given their past
history of spontaneous abortions, the couple was eager to
have children, and since the cytogenetic analysis result of
this fetus was negative, they decided to continue the preg-
nancy. The proband was born at 39 weeks and 2 days of
gestation by vaginal delivery. His birth weight was 2,688 g
(25th centile), length was 47.5 cm (25th centile), and head
circumference was 33.5 cm (75th centile). Apgar scores
of the infant were 8 at 1 min and 8 at 5 min. Notable
physical features included skull joint separation, single
transverse palmar crease on both hands, craniofacial
dysmorphism including round face, low-set and dysplas-
tic ears (Figure 2). Ultrasonic tests of brain/abdomen
and cardiovascular examination were postponed accor-
ding to the parents of the affected infant.apparently normal karyotype 46,XY at a resolution of 400 bands.
Figure 2 Clinical features of the newborn proband. The proband was born with skull joint separation, round face, low-set and dysplastic ears.
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Peripheral blood samples were obtained from the proband
and his parents for cytogenetic analyses. Sample collection
procedures were approved by Guangdong Women and
Children Hospital Institutional Review Board and Ethics
Committee of Guangzhou Medical College, China. The
family gave their written informed consent. Peripheral
blood samples were cultured for 72 hours in RPMIFigure 3 GTG banded karyotype of the proband. The proband indicatemedium, after that metaphase chromosomes were ana-
lyzed by the standard G-banding technique.
The cytogenetic analysis of the peripheral blood sam-
ple from the proband initially revealed a possible
chromosome 18p deletion, but the breakpoint and the
deletion region were difficult to determine with the li-
mited resolution of chromosome banding technique
(Figure 3).d a possible abnormal karyotype [46,XY,?del(18)(p11.3)].
Figure 4 Array-CGH analysis results of the proband. The anaylsis indicated a combined of 7q duplication and 18p deletion in the proband.
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Genomic DNA from the proband was isolated from the
whole blood by standard procedures using Fuji DNA
Blood Mini kit. Array-based CGH analysis was performed
using Agilent’s 8 × 60 K commercial arrays (AgilentTechnologies, CA, USA), which consist of 60,000 oligo-
nucleotide probes and evaluate the whole genome with
an effective backbone resolution of roughly 50 Kb. 500 ng
of experimental and gender-matched reference DNAs
(Promega, Madison, WI) were digested with Alu I and Rsa
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labeled with cyanine 3-dUTP and cyanine 5-dUTP re-
spectively. Labeled experimental and reference DNAs
were purified, combined, denatured, pre-annealed, and hy-
bridized to the microarrays in a rotating oven (20 rpm) at
65°C for 24 hours. The data was analyzed with Agilent
Genomic Workbench Lite Edition 6.5.0.18 software
(Agilent Technologies). Aberrations were identified using
the Agilent Genomic Workbench Lite software via the
Aberration Detection Method-2 algorithm with a sensiti-
vity threshold of 6.0 and a data filter that rejected aberra-
tions that did not include at least five probes with a log2
set of 0.25. All quality control metrics passed.
As shown in Figure 4, a combination of 18p deletion
and 7q duplication was identified in the proband by array-
CGH analysis. A deletion spanning approximately 14 Mb
was detected at 18p11.32-p11.21, with the deleted base
pair coordinate ranging from 4,316 to 14,216,904 (hg18).
Array-based CGH analysis also identified a duplication of
about 11.2 Mb that involving the 7q36.1- q36.3 region,
with distal breakpoint falling between 147,580,628 bp (last
duplicated oligomer) and 158,781,397 bp (first normal
oligomer).
Origin of the translocation
The array-CGH analysis results of the proband highly in-
dicated that the unbalanced translocation could be inhe-
rited from a balanced translocation carrier parent. To
trace the origin of the translocation, cytogenetic analyses
were provided to the proband’s parents, even though they
had received cytogenetic analyses before at another hos-
pital and revealed apparent normal karyotypes. With the
guidance of array-based CGH results of the proband, the
cytogenetic analyses revealed an abnormal karyotype [46,Figure 5 GTG banded karyotype of the proband’s father. The karyotype oXY, t(7;18) (q36; p11.2)] of the proband’s father (Figure 5),
and a normal karyotype [46,XX] of the proband’s mother.
The cytogenetics suggested that the father of the proband
was a carrier of the balanced translocation.
Discussion and conclusions
It was reported that parent with balanced translocation
has a 50% chance to deliver chromosomes with unbal-
anced translocation to proband, and it could be difficult
to notice until the proband was born. Unlike previous
report [11], we showed another case that the proband
carried an unbalanced translocation inherited from a
balanced translocation carrier parent, which resulted in
partial monosomy for 18p and partial trisomy for 7q.
The 18p deletion spanned approximately 14 Mb and the
7q duplication about 11.2 Mb, which meant the deriva-
tive chromosome was 2.8 Mb shorter than chromosome
18. Because the derivative chromosome and the original
chromosome 18 were similar in size, and the replacement
region 7q36.1-q36.3 was also light stained like 18p11.32-
p11.21 region in cytogenetic analysis of prenatal samples
at resolutions of 350–400 bands, karyotyping did not reli-
ably detect the anomalies, and led to the prenatal missed
diagnosis of the case. The newborn infant was demon-
strated with craniofacial dysmorphism and multiple mal-
formations, and cytogenetic analysis of his peripheral
blood sample was applied, indicating a possible abnormal
karyotype, but the breakpoint and the deletion region
were difficult to determine at resolutions of 450–500
bands. Array-based CGH analysis was applied to the
proband, identified the chromosomal abnormalities and
mapped those changes onto the genome sequence. On
the basis of search of the genes in the region between
18p11.32 and 18p11.21 in the NCBI MapViewer, aboutf the father indicated an abnormal karyotype [46,XY, t(7;18) (q3?6; p11.2)].
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(Data not shown). Holoprosencephaly (HPE) severely af-
fects the craniofacial development of the infants. TGFB-
induced factor homeobox 1 (TGIF1) mutation, leading to
the loss of function of TGIF1, promotes the pathogenesis
of HPE in the mouse model [12]. Twisted gastrulation
homolog 1 (TWSG1) has been demonstrated to be also
associated with HPE [13,14]. Accordingly, TGIF1 and
TWSG1 deficiency maybe important factor for the feature
of craniofacial dysmorphism and skull joint separation of
the proband. As for other two genes, THO complex is re-
ported to influence the cerebellar congenital hypoplasia,
Cell death-inducing DFFA-like effector a (CIDEA) is asso-
ciated with fat and diabetes [15,16]. Thus, refined and
complete diagnosis are needed to provide additional im-
portant manifestations information. Based on the spe-
cific genetic diagnosis of the affected infant, the clinical
manifestations could also include mental retardation
and growth retardation [17-19]. Accordingly, compre-
hensive genetic counseling and medical care were pro-
vided to the family for better preparation for the health
and educational needs of the neonate.
In review of the case, several overlooked points leading
to the missed diagnosis should be discussed and certain
quality control strategies should be adopted to avoid
similar problems in the future. Firstly, there was a past
history of spontaneous abortions in the family, but POC
samples were not analyzed. As indicated in the previous
studies, spontaneous abortions affect 10–15% of all cli-
nically recognized human pregnancies, and approxi-
mately 50% of first-trimester miscarriages are resulted
from fetal chromosome abnormalities [20,21]. Cytogen-
etic analysis and (or) array-based CGH analysis of POC
samples may provide valuable insights into the possible
genetic causes of miscarriage and help predict the recur-
rence risk for subsequent pregnancies. Secondly, the
couple has received cytogenetic analyses after spontaneous
abortions at another hospital, but karyotyping failed to de-
tect the balanced translocation. As estimated, balanced
chromosomal rearrangements represented in about 0.19%
in the general population, and it is common to observe
decreased fertility or high rates of miscarriage in them
[22]. Karyotyping is just able to detect a portion of the
chromosomal rearrangements, because of its limited-
resolution. Array-based CGH analysis of POC samples
contributes to reveal submicroscopic chromosomal abnor-
malities, and provides valuable insights into the possible
genetic causes of miscarriage [21,23]. Thirdly, when pre-
natal ultrasound examination of the fetus showed abnor-
mal findings, only routine analysis of fetal chromosomes
was applied, which failed to identify the unbalanced trans-
location and led to the prenatal missed diagnosis of the
case. As prior studies suggested, about 71% of the clinic-
ally significant copy number alterations (CNAs) aresmaller than 10 Mb in size, and are unlikely to be de-
tected by routine analysis of fetal chromosomes [24].
Array-based CGH analysis possesses a number of sig-
nificant advantages over conventional cytogenetic and
other molecular cytogenetic techniques, and can en-
hance the detection rate by 10 to 16 percent of pregnan-
cies with fetal ultrasound anomalies but not detected by
routine analysis of fetal chromosomes [1,25-27]. The
American Congress of Obstetricians and Gynecologists
(ACOG) and the Society of Maternal Fetal-Medicine
(SMFM) have recommended prenatal chromosomal
microarray analysis as a first-line test in the case of abnor-
mal ultrasound findings. Array-based CGH and karyotyp-
ing techniques are complemented by diverse detection
spectrums and resolutions, and a combination of these
methods can contribute to provide optimal genetic diag-
nosis and facilitate comprehensive medical care, as well as
accurate recurrence risk counseling for the family. Given
that the array-CGH analysis will not introduce additional
risk for patients, it is reasonable to recommend that
women with fetuses showing sonographic anomalies or de
novo chromosome abnormalities already undergoing inva-
sive testing should take the array-CGH test as an adjunct
to conventional cytogenetic tests and molecular cyto-
genetic analysis [7,28].
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